Cost Conversations About Anticoagulation Between Patients With Atrial Fibrillation and Their Clinicians: A Secondary Analysis of a Randomized Clinical Trial

IMPORTANCE: How patients with atrial fibrillation (AF) and their clinicians consider cost in forming care plans remains unknown. OBJECTIVE: To identify factors that inform conversations regarding costs of anticoagulants for treatment of AF between patients and clinicians and outcomes associated with...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JAMA Netw Open
Main Authors: Kamath, Celia C., Giblon, Rachel, Kunneman, Marlene, Lee, Alexander I., Branda, Megan E., Hargraves, Ian G., Sivly, Angela L., Bellolio, Fernanda, Jackson, Elizabeth A., Burnett, Bruce, Gorr, Haeshik, Torres Roldan, Victor D., Spencer-Bonilla, Gabriella, Shah, Nilay D., Noseworthy, Peter A., Montori, Victor M., Brito, Juan P.
Formato: Artigo
Idioma:Inglês
Publicado: American Medical Association 2021
Assuntos:
Original Investigation
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8278261/
https://ncbi.nlm.nih.gov/pubmed/34255051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2021.16009
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares